The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion

American Journal of Reproductive Immunology

Volumn 53, Issue 4, 2005, Pages 166-171

  Kalinka, Jarosław ^a   Szekeres Bartho, Julia ^b,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF PÉCS   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Dydrogesterone; Early pregnancy; Progesterone; Progesterone induced blocking factor; Threatened abortion

Indexed keywords

DYDROGESTERONE; ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; BLOCKING FACTOR; CELL ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE DETERMINATION; HUMAN; IMMINENT ABORTION; LYMPHOCYTE; OUTCOMES RESEARCH; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; URINALYSIS;

EID: 15844365871     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00261.x     Document Type: Article

References (25)

1. Stites DP, Bugbee S, Siiteri PK: Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation - relevance to immunosuppression in pregnancy. J Reprod Immunol 1983; 5:215-228.
2. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C, Romagnani S, Maggi E: Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established T cell clones. J Immunol 1995; 155:128-133.
3. Choi BC, Polgar K, Xiao L, Hill JA: Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000; 15(Suppl. 1):46-59.
4. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A, Pacsa AS: Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 1985; 9:15-19.
5. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G: Immunoregulatory effects of a suppressor factor from healthy pregnant women s lymphocytes after progesterone induction. Cell Immunol 1989; 122:281-294.
6. Szekeres-Bartho J, Par G, Dombay GY, Smart YC, Volgyi Z: The anti-abortive effect of PIBF in mice is manifested by modulating NK activity. Cell Immunol 1997; 177:194-199.
7. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achacz I: Progesterone and non-specific immunological mechanisms in pregnancy. Am J Reprod Immunol 1997; 38:176-182.
8. Szekeres-Bartho J, Szekeres GY, Debre P, Autran B, Chaouat G: Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 990; 125:273-283.
9. Faust Z, Laškarin G, Rukavina D, Szekeres-Bartho J: Progesterone induced blocking factor inhibits degranulation of NK cells. Am J Reprod Immunol 1999; 42:71-75.
10. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J: Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48:77-86.
11. Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A: Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneus abortions. Hum Reprod 2000; 15:2011-2017.
12. Szereday L, Varga P, Szekeres-Bartho J: Cytokine production in pregnancy. Am J Reprod Immunol 1997; 38:418-422.
13. Sacks GP, Redman CW, Sargent IL: Monocytes are primed to produce the TH1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cell. Clin Exp Immunol 2003; 131:490-497.
14. Chaouat G: Innately moving away from the TH1/Th2 paradigm in pregnancy. Clin Exp Immunol 2003; 131:393-395.
15. Szekeres-Bartho J, Wegmann TG: A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996; 31:81-95.
16. El-Zibdeh MY: Randomised clinical trial comparing the efficacy of dydrogesterone, human chorionic gonadothropin or no treatment in the reduction of spontaneous abortion. Gynecol Endocrinol 2001; 15:44.
17. Polgár B, Nagy E, Mikó É, Varga P, Szekeres-Barthó J: Urinary Progesterone- Induced Blocking Factor concentration is related to pregnancy outcome. Biol Reprod 2004; 71:1699-1705.
18. Joachim R, Zenclussen AC, Polgar B, Douglas AJ, Fest S, Knackstedt M, Klapp BF, Arck PC: The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 2003; 68:931-940.
19. Milligan SR, Finn CA: Minimal progesterone support required for the maintenance of pregnancy in mice. Hum Reprod 1997; 12:602-607.
20. Aksoy S, Celikkanat H, Senoz S, Gokmen P: The prognostic value of serum estradiol, progesterone, testosterone, and free testosterone levels in detecting early abortions. Eur J Obstet Gynecol Reprod Biol 1996; 67:5-8.
21. Arck P: Stress and embryo implantation. J Gynecol Obstet Biol Reprod 2004; 33:S40-S42.
22. Sotiriadis A, Papatheodorou S, Makrydimas G: Threatened miscarriage: evaluation and management. Br Med J 2004; 329:152-155.
23. Oates-Whitehead RM, Haas DM, Carrier JA: Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2003; CD003511.
24. Blois SM, Joachim R, Kandil J, Margni R, Tometten M, Klapp BF, Arck PC: Depletion of CD8+ cells abolishes the pregnancy protective effect of progesteron substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 2004; 172:5893-5899.
25. Raghupathy R, Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J: Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent abortion. BJOG published online 1 March 2005; doi: 10.1111/j.1471-0528.2005.00633.x